# OnCo record paper-zeidan-lancet-haematol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-zeidan-lancet-haematol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-zeidan-lancet-haematol" ;
  schema:name "Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial"@en ;
  schema:description "Paper cited by one target page, indexed on Europe PMC as PubMed record 38065203 and published in The Lancet Haematology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-zeidan-lancet-haematol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s2352-3026(23)00333-2>, <https://pubmed.ncbi.nlm.nih.gov/38065203/>, <https://europepmc.org/article/MED/38065203> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s2352-3026(23)00333-2> ;
  schema:datePublished "2024"^^xsd:gYear ;
  schema:author "Zeidan AM, Ando K, Rauzy O, et al." ;
  onco:related <https://onco.cc/targets/tim3/> ;
  onco:journals <https://onco.cc/journals/lancet-haematology/> .